Zobrazeno 1 - 10
of 20
pro vyhledávání: '"K P, Kulkarni"'
Publikováno v:
Journal of Lipid Research, Vol 38, Iss 11, Pp 2353-2364 (1997)
Of the several existing methods for quantification of major subspecies of high density lipoprotein (HDL), HDL2 and HDL3, the methods based upon double precipitation are particularly useful for large-scale studies or for routine assay because of their
Externí odkaz:
https://doaj.org/article/1fe1d4bbfa3143559df42728b5a921a5
Publikováno v:
Journal of Lipid Research, Vol 36, Iss 11, Pp 2291-2302 (1995)
Low density lipoprotein (LDL) particles are heterogeneous in size, density, and chemical composition; small, dense LDL may be more atherogenic than large, buoyant LDL. We have developed a rapid microscale method called LDL VAP-II (Vertical Auto Profi
Externí odkaz:
https://doaj.org/article/6721aeecd47c419d96b45407bbf6e301
Publikováno v:
Journal of Lipid Research, Vol 35, Iss 1, Pp 159-168 (1994)
We have developed a high resolution microvolume Vertical Auto Profile (VAP) method for the simultaneous measurement of cholesterol in all lipoprotein classes, including lipoprotein[a] (Lp[a]) and intermediate density lipoprotein (IDL). This method, d
Externí odkaz:
https://doaj.org/article/656abe4c1461466bbc66fddbfdb46a54
Autor:
R K Marwaha, K P Kulkarni
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 23, Iss 5, Pp 1088-1089 (2012)
Externí odkaz:
https://doaj.org/article/1185a8e119e843268d78b9e0280cada1
Publikováno v:
Indian Pediatrics. 48:821-824
Autor:
K. Jagadish Kumar, null Nayana, Rekha Harish, Ashu Jamwal, Thirunavukkarasu Arun Babu, Venkatesh Chandrasekaran, Sarita Sardana, Raj Narain, R. K. Marwaha, K. P. Kulkarni, Satya Prakash Yadav, Gaurav Kharya
Publikováno v:
Indian Pediatrics. 48:74-80
Publikováno v:
Indian Pediatrics. 47:633-636
Autor:
R K, Marwaha, K P, Kulkarni
Publikováno v:
Indian pediatrics. 48(10)
Publikováno v:
Journal of the Indian Medical Association. 109(2)
This study was designed to demonstrate the efficacy and safety of pharmacokinetically enhanced amoxicillin/clavulanic acid 2000 mg/125 mg extended release formulation (ER), than conventional formulations against community-acquired respiratory tract p
Autor:
R K, Marwaha, K P, Kulkarni
Publikováno v:
Indian pediatrics. 48(1)